Exchange Announcement • 14 Jun 2022 01:21
Exchange Announcement • 10 Jun 2022 00:16
Exchange Announcement • 10 Jun 2022 00:13
Exchange Announcement • 04 Jun 2022 00:18
Exchange Announcement • 04 Jun 2022 00:16
ENTITY
Genocea Biosciences (GNCA US)
Genocea Biosciences (GNCA US)
Health Care • United States
Genocea Biosciences, Inc. operates as a biotechnology company. The Company develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. Genocea Biosciences uses priority identification platform to build a pipeline of immunotherapies for genital herpes and neoantigen cancer vaccine.
more
x